COFEPRIS decided to introduce ten regulations for health purposes, and three of these were specifically for medical devices. This prioritization underscores the importance of our contributions…
In Conversation
Our portfolio is deliberately diversified to mitigate reliance on any single segment
Millions of lives have been saved, millions of people are on treatment, and millions of babies have been born HIV-free. We have achieved a lot, but…
My goal has been to try to develop strategies and approaches that – when implemented at scale – could really have an impact on HIV incidence
U=U is our good news strategy to end HIV as a public health threat – simply communicating this news has profound individual and population-level impacts
The days of siloed approaches to chronic conditions such as HIV are over
We now have the scientific tools to end the HIV epidemic; the challenge lies in delivery
ISPOR sits at the nexus of science and policy, and we advocate that the best policies always rest on a foundation of good science
Astellas has steadily developed its immuno-oncology (IO) pipeline via both organic and inorganic means in recent years, with its early-phase IO projects now overseen by industry…
In 2023, we face a new digital relations landscape where a customer and a brand more and more rely on personal data exchange and unique communication…
There is trust in [Colombia], and regardless of which shade of government is in power, we will not stop investing in its future
Having a Latin American dimension, not only in the business but also in management, is a catalyst for sustainability
